Icahn's Hedge Fund Has New Stakes In Genzyme and Childrens Place, Among Others

|
Includes: ABI, ACOR, CMZ, HET, PLCE, SNY, TTWO
by: Lon Juricic

Carl Icahn's Icahn Capital Management LP released its latest 13F for the quarter ended September 30, 2007. Below is a summary:

New Positions:
Acorda (NASDAQ:ACOR) 16,293 sharesApplera Corp-Applied Biosystems Group (NYSE:ABI) 649,026 sharesCompton Petroleum Corp. (CMZ) 3,500,880 sharesGenzyme Corp. (GENZ) 1,518,463 sharesHarrah's Entertainment Inc. (HET) 1,842,800 sharesMGI Pharma Inc. (OGN) 606,518 sharesTake-Two Interactive Software Inc. (NASDAQ:TTWO) 462,037 sharesThe Childrens Place Retail Stores, Inc. (NASDAQ:PLCE) 1,128,001 sharesRaised Positions:Anadarko Petroleum Corp. (NYSE:APC) from 4,520,294 shares to 13,758,160 sharesBEA Systems (BEAS) from 7,944,293 to 13,578,160 sharesBiogen (BIIG) from 2,740,000 shares to 8,825,816 sharesLions Gate Entertainment Corp. (LGF) from 4,119,918 shares to 4,289,508 sharesMacy's (NYSE:M) from 2,368,560 shares to 4,016,669 sharesMotorola (MOT) from 55,290,640 shares to 60,466,400 sharesRegeneron Pharmaceuticals Inc. (NASDAQ:REGN) from 2,270,024 shares to 2,508,001 sharesLowered Positions:Clear Channel Communications Inc. (NYSE:CCU) from 1,466,640 to 0Global Payments Inc. (NYSE:GPN) from 1,008,779 to 0MeadWestvaco Corporation (MWV) from 3,781,120 shares to 2,243,101Pride International Inc. (NYSE:PDE) from 4,527,245 shares to 0Rowan Companies Inc. (NYSE:RDC) from 3,239,600 shares to 2,317,979Talisman Energy Inc. (NYSE:TLM) from 4,156,663 shares to 0Temple-Inland Inc. (NYSE:TIN) from 6,046,992 shares to 2,601,056

Maintained Positions:
Adventrx Pharmaceuticals Inc. (ANX), Blockbuster Inc. (BBI), CSX Corp. (NYSE:CSX), Cyberonics Inc. (NASDAQ:CYBX), Enzon Pharmaceuticals Inc. (OTCQX:ENZN), Lear Corp. (NYSE:LEA), Lincoln National Corp. (NYSE:LNC), Quest Resource Corp. (QRCP), Time Warner Inc. (NYSE:TWX), Unum Group (NYSE:UNM), WCI Communities Inc. (WCI), Williams Companies Inc. (NYSE:WMB).

About this article:

Expand
Problem with this article? Please tell us. Disagree with this article? .